BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34690281)

  • 1. The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences.
    Fursa O; Mocroft A; Lazarus JV; Amele S; Lundgren J; Matulionyte R; Rasmussen LD; Rockstroh JK; Parczewski M; Jilich D; Moreno S; Vassilenko A; Lacombe K; Wandeler G; Borodulina E; Brännström J; Wiese L; Orkin C; Behrens GMN; Mansinho K; Portu JJ; Peters L;
    AIDS; 2022 Mar; 36(3):423-435. PubMed ID: 34690281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort.
    Fursa O; Reekie J; Kuzin I; Hetman L; Kryshchuk A; Starychenko O; Hrytsaiuk N; Khodus I; Nyzhnyk A; Rakhuba V; Kovalevska M; Maistat T; Pryhoda I; Ahieieva M; Varvarovska O; Valdenmaiier O; Lundgren J; Peters L;
    J Int AIDS Soc; 2023 Sep; 26(9):e26166. PubMed ID: 37705358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals.
    Peters L; Laut K; Resnati C; Del Campo S; Leen C; Falconer K; Trofimova T; Paduta D; Gatell J; Rauch A; Lacombe K; Domingo P; Chkhartishvili N; Zangerle R; Matulionyte R; Mitsura V; Benfield T; Zilmer K; Khromova I; Lundgren J; Rockstroh J; Mocroft A;
    AIDS; 2018 Sep; 32(14):1995-2004. PubMed ID: 29912062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
    Baumann L; Braun DL; Cavassini M; Stoeckle M; Bernasconi E; Schmid P; Calmy A; Haerry D; Béguelin C; Fux CA; Wandeler G; Surial B; Rauch A
    Liver Int; 2024 Jan; 44(1):169-179. PubMed ID: 37850685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut.
    Wegener M; Brooks R; Speers S; Nichols L; Villanueva M
    Public Health Rep; 2024; 139(2):208-217. PubMed ID: 37232422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
    Ross J; Rupasinghe D; Avihingsanon A; Lee MP; Pujari S; Sharp G; Kumarasamy N; Khusuwan S; Khol V; Agus Somia IK; Pham TN; Kiertiburanakul S; Choi JY; Duy Do C; Sohn AH; Jiamsakul A;
    PLoS One; 2023; 18(6):e0287909. PubMed ID: 37379314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.
    Young J; Wang S; Lanièce Delaunay C; Cooper CL; Cox J; Gill MJ; Hull M; Walmsley S; Wong A; Klein MB;
    Int J Drug Policy; 2023 Apr; 114():103981. PubMed ID: 36893502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
    Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
    Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    Isfordink CJ; Smit C; Boyd A; de Regt MJA; Rijnders BJA; van Crevel R; Ackens RP; Reiss P; Arends JE; van der Valk M;
    AIDS; 2022 May; 36(6):773-783. PubMed ID: 34999607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV.
    Requena MB; Grabar S; Lanoy E; Pialoux G; Billaud E; Duvivier C; Merle P; Piroth L; Tattevin P; Salmon D; Weiss L; Costagliola D; Lacombe K
    AIDS; 2023 Jul; 37(8):1297-1306. PubMed ID: 37070541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.
    Amele S; Peters L; Sluzhynska M; Yakovlev A; Scherrer A; Domingo P; Gerstoft J; Viard JP; Gisinger M; Flisiak R; Bhaghani S; Ristola M; Leen C; Jablonowska E; Wandeler G; Stellbrink H; Falconer K; D'Arminio Monforte A; Horban A; Rockstroh JK; Lundgren JD; Mocroft A;
    HIV Med; 2019 Apr; 20(4):264-273. PubMed ID: 30734998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods.
    Brooks R; Wegener M; Speers S; Nichols L; Sideleau R; Valeriano T; Buchelli M; Villanueva M
    Health Promot Pract; 2023 Sep; 24(5):1039-1049. PubMed ID: 37439600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
    Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
    Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
    Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
    J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.
    Chen PH; Yenokyan K; Fojo AT; Hutton HE; Lesko CR; McCaul ME; Yang C; Cachay ER; Crane HM; Jacobson JM; Kim HN; Kitahata MM; Mayer KH; Moore RD; Napravnik S; Saag M; Lau B; Chander G
    Drug Alcohol Depend; 2022 Dec; 241():109673. PubMed ID: 36332596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
    Mocroft A; Lundgren J; Gerstoft J; Rasmussen LD; Bhagani S; Aho I; Pradier C; Bogner JR; Mussini C; Uberti Foppa C; Maltez F; Laguno M; Wandeler G; Falconer K; Trofimova T; Borodulina E; Jevtovic D; Bakowska E; Kase K; Kyselyova G; Haubrich R; Rockstroh JK; Peters L;
    Clin Infect Dis; 2020 May; 70(10):2131-2140. PubMed ID: 31504296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
    Berenguer J; Gil-Martin Á; Jarrin I; Montes ML; Domínguez L; Aldámiz-Echevarría T; Téllez MJ; Santos I; Troya J; Losa JE; Serrano R; De Guzmán MT; Calvo MJ; González-García JJ;
    AIDS; 2019 Mar; 33(4):685-689. PubMed ID: 30829744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
    Doyle JS; van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME
    Clin Infect Dis; 2021 Oct; 73(7):e2164-e2172. PubMed ID: 33010149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.